Summit Therapeutics
SMMT
SMMT
14 hedge funds and large institutions have $30.5M invested in Summit Therapeutics in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Holders
14
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$210K | |
| 2 | +$28K | |
| 3 | +$22.3K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$11 |
Top Sellers
| 1 | -$89K | |
| 2 | -$83.2K | |
| 3 | -$60.1K | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$59.7K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$16K |